Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer.

Farago AF, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP, Zhong J, Rangachari D, Barbie DA, Phat S, Myers DT, Morris R, Kem M, Dubash TD, Kennedy EA, Digumarthy SR, Sequist LV, Hata AN, Maheswaran S, Haber DA, Lawrence MS, Shaw AT, Mino-Kenudson M, Dyson NJ, Drapkin BJ.

Cancer Discov. 2019 Aug 15. doi: 10.1158/2159-8290.CD-19-0582. [Epub ahead of print]

PMID:
31416802
2.

Correction: High piezo-resistive performances of anisotropic composites realized by embedding rGO-based chitosan aerogels into open cell polyurethane foams.

Zhai T, Verdolotti L, Kaciulis S, Cerruti P, Gentile G, Xia H, Stanzione M, Buonocore GG, Lavorgna M.

Nanoscale. 2019 May 30;11(21):10556. doi: 10.1039/c9nr90108f.

PMID:
31115429
3.

High piezo-resistive performances of anisotropic composites realized by embedding rGO-based chitosan aerogels into open cell polyurethane foams.

Zhai T, Verdolotti L, Kacilius S, Cerruti P, Gentile G, Xia H, Stanzione M, Buonocore GG, Lavorgna M.

Nanoscale. 2019 May 9;11(18):8835-8844. doi: 10.1039/c9nr00157c. Erratum in: Nanoscale. 2019 May 30;11(21):10556.

PMID:
31012901
4.

Mouse ANKRD31 Regulates Spatiotemporal Patterning of Meiotic Recombination Initiation and Ensures Recombination between X and Y Sex Chromosomes.

Papanikos F, Clément JAJ, Testa E, Ravindranathan R, Grey C, Dereli I, Bondarieva A, Valerio-Cabrera S, Stanzione M, Schleiffer A, Jansa P, Lustyk D, Fei JF, Adams IR, Forejt J, Barchi M, de Massy B, Toth A.

Mol Cell. 2019 Jun 6;74(5):1069-1085.e11. doi: 10.1016/j.molcel.2019.03.022. Epub 2019 Apr 15.

PMID:
31000436
5.

Vegetable Tannin as a Sustainable UV Stabilizer for Polyurethane Foams.

Oliviero M, Stanzione M, D'Auria M, Sorrentino L, Iannace S, Verdolotti L.

Polymers (Basel). 2019 Mar 12;11(3). pii: E480. doi: 10.3390/polym11030480.

6.

Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment.

Pisaturo M, Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, Messina V, Sangiovanni V, Claar E, Precone D, Stornaiuolo G, Stanzione M, Gentile I, Brancaccio G, Martini S, Masiello A, Megna AS, Coppola C, Federico A, Sagnelli E, Persico M, Lanza AG, Marrone A, Gaeta GB, Coppola N.

Antivir Ther. 2019 Feb 13. doi: 10.3851/IMP3296. [Epub ahead of print]

PMID:
30758299
7.

Characterization of sustainable polyhydroxyls, produced from bio-based feedstock, and polyurethane and copolymer urethane-amide foams.

Stanzione M, Russo V, Oliviero M, Verdolotti L, Sorrentino A, Di Serio M, Tesser R, Iannace S, Lavorgna M.

Data Brief. 2018 Sep 29;21:269-275. doi: 10.1016/j.dib.2018.09.077. eCollection 2018 Dec.

8.

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets.

Colagrossi L, Salpini R, Scutari R, Carioti L, Battisti A, Piermatteo L, Bertoli A, Fabeni L, Minichini C, Trimoulet P, Fleury H, Nebuloso E, De Cristofaro M, Cappiello G, Spanò A, Malagnino V, Mari T, Barlattani A, Iapadre N, Lichtner M, Mastroianni C, Lenci I, Pasquazzi C, De Sanctis GM, Galeota Lanza A, Stanzione M, Stornaiuolo G, Marignani M, Sarmati L, Andreoni M, Angelico M, Ceccherini-Silberstein F, Perno CF, Coppola N, Svicher V.

Viruses. 2018 Jul 9;10(7). pii: E363. doi: 10.3390/v10070363.

9.

ATR is a multifunctional regulator of male mouse meiosis.

Widger A, Mahadevaiah SK, Lange J, ElInati E, Zohren J, Hirota T, Pacheco S, Maldonado-Linares A, Stanzione M, Ojarikre O, Maciulyte V, de Rooij DG, Tóth A, Roig I, Keeney S, Turner JMA.

Nat Commun. 2018 Jul 5;9(1):2621. doi: 10.1038/s41467-018-04850-0.

10.

Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review.

Goossens N, de Vito C, Mangia A, Clément S, Cenderello G, Barrera F, D'Ambrosio R, Coppola N, Zampino R, Stanzione M, Adinolfi LE, Wedemeyer H, Semmo N, Müllhaupt B, Semela D, Malinverni R, Moradpour D, Heim M, Trincucci G, Rubbia-Brandt L, Negro F; BOSTIC Study Group.

J Viral Hepat. 2018 Aug;25(8):920-929. doi: 10.1111/jvh.12891. Epub 2018 Apr 17. Review.

PMID:
29532619
11.

Virological patterns of HCV patients with failure to interferon-free regimens.

Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, Messina V, Sangiovanni V, Adinolfi LE, Claar E, Precone D, Stornaiuolo G, Stanzione M, Ascione T, Caroprese M, Zampino R, Parrilli G, Gentile I, Brancaccio G, Iovinella V, Martini S, Masarone M, Fontanella L, Masiello A, Sagnelli E, Punzi R, Salomone Megna A, Santoro R, Gaeta GB, Coppola N.

J Med Virol. 2018 May;90(5):942-950. doi: 10.1002/jmv.25022. Epub 2018 Feb 1.

PMID:
29315640
12.

Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation.

Macera M, Stanzione M, Messina V, D'Adamo G, Sangiovanni V, Mioglioresi L, Fontanella L, De Pascalis S, Stornaiuolo G, Galeota Lanza A, Ascione T, Sagnelli E, Gentile I, Piai G, Gaeta GB, Coppola N.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1800-1802. doi: 10.1016/j.cgh.2017.05.032. Epub 2017 May 26. No abstract available.

PMID:
28552801
13.

The PRDM9 KRAB domain is required for meiosis and involved in protein interactions.

Imai Y, Baudat F, Taillepierre M, Stanzione M, Toth A, de Massy B.

Chromosoma. 2017 Dec;126(6):681-695. doi: 10.1007/s00412-017-0631-z. Epub 2017 May 19.

14.

Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.

Aliperta R, Welzel PB, Bergmann R, Freudenberg U, Berndt N, Feldmann A, Arndt C, Koristka S, Stanzione M, Cartellieri M, Ehninger A, Ehninger G, Werner C, Pietzsch J, Steinbach J, Bornhäuser M, Bachmann MP.

Sci Rep. 2017 Feb 16;7:42855. doi: 10.1038/srep42855.

15.

ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.

Coppola N, De Pascalis S, Messina V, Di Caprio G, Martini S, de Stefano G, Starace M, Stornaiuolo G, Stanzione M, Ascione T, Minichini C, Sangiovanni V, Zampino R, Calò F, Rinaldi L, Persico M, Federico A, Buonomo AR, Borgia G, Gaeta GB, Filippini P, Gentile I.

Antivir Ther. 2017;22(7):551-558. doi: 10.3851/IMP3134. Epub 2017 Feb 6.

PMID:
28165327
16.

Meiotic DNA break formation requires the unsynapsed chromosome axis-binding protein IHO1 (CCDC36) in mice.

Stanzione M, Baumann M, Papanikos F, Dereli I, Lange J, Ramlal A, Tränkner D, Shibuya H, de Massy B, Watanabe Y, Jasin M, Keeney S, Tóth A.

Nat Cell Biol. 2016 Nov;18(11):1208-1220. doi: 10.1038/ncb3417. Epub 2016 Oct 10.

17.

CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection.

Coppola N, Zampino R, Bellini G, Stanzione M, Capoluongo N, Marrone A, Macera M, Adinolfi LE, Giudice EM, Gentile I, Sagnelli E, Rossi F.

Dig Liver Dis. 2016 Nov;48(11):1364-1369. doi: 10.1016/j.dld.2016.07.005. Epub 2016 Jul 15.

PMID:
27476469
18.

Alignment of Homologous Chromosomes and Effective Repair of Programmed DNA Double-Strand Breaks during Mouse Meiosis Require the Minichromosome Maintenance Domain Containing 2 (MCMDC2) Protein.

Finsterbusch F, Ravindranathan R, Dereli I, Stanzione M, Tränkner D, Tóth A.

PLoS Genet. 2016 Oct 19;12(10):e1006393. doi: 10.1371/journal.pgen.1006393. eCollection 2016 Oct.

19.
20.

Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment.

Zampino R, Alessio L, Marrone A, Stanzione M, Boemio A, Grandone A, Minichini C, Pisaturo M, Starace M, Adinolfi LE, Sagnelli E, Coppola N.

Infez Med. 2015 Jun;23(2):134-9.

21.

Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B.

Zampino R, Coppola N, Cirillo G, Boemio A, Grandone A, Stanzione M, Capoluongo N, Marrone A, Macera M, Sagnelli E, Adinolfi LE, del Giudice EM.

Dig Dis Sci. 2015 Oct;60(10):3005-10. doi: 10.1007/s10620-015-3716-7. Epub 2015 May 19.

PMID:
25986529
22.

The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B.

Coppola N, Zampino R, Bellini G, Stanzione M, Capoluongo N, Marrone A, Macera M, Pasquale G, Boemio A, Maione S, Adinolfi LE, Del Giudice EM, Sagnelli E, Rossi F.

Clin Microbiol Infect. 2015 Jun;21(6):609.e1-4. doi: 10.1016/j.cmi.2015.02.021. Epub 2015 Mar 5.

23.

TM6SF2 E167K variant is associated with severe steatosis in chronic hepatitis C, regardless of PNPLA3 polymorphism.

Coppola N, Rosa Z, Cirillo G, Stanzione M, Macera M, Boemio A, Grandone A, Pisaturo M, Marrone A, Adinolfi LE, Sagnelli E, Miraglia del Giudice E.

Liver Int. 2015 Aug;35(8):1959-63. doi: 10.1111/liv.12781. Epub 2015 Jan 27.

PMID:
25581573
24.

Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.

Zampino R, Pisaturo MA, Cirillo G, Marrone A, Macera M, Rinaldi L, Stanzione M, Durante-Mangoni E, Gentile I, Sagnelli E, Signoriello G, Miraglia Del Giudice E, Adinolfi LE, Coppola N.

Ann Hepatol. 2015 Jan-Feb;14(1):75-82.

25.

Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression.

Zampino R, Coppola N, Cirillo G, Boemio A, Minichini C, Marrone A, Stanzione M, Starace M, Durante-Mangoni E, Sagnelli E, Restivo L, Salzillo G, Fascione MC, Nevola R, Del Giudice EM, Adinolfi LE.

World J Hepatol. 2014 Sep 27;6(9):677-84. doi: 10.4254/wjh.v6.i9.677.

26.

Cannabinoid receptor 2-63 QQ variant is associated with persistently normal aminotransferase serum levels in chronic hepatitis C.

Coppola N, Zampino R, Sagnelli C, Bellini G, Marrone A, Stanzione M, Capoluongo N, Boemio A, Minichini C, Adinolfi LE, Maione S, Del Giudice EM, Sagnelli E, Rossi F.

PLoS One. 2014 Jun 18;9(6):e99450. doi: 10.1371/journal.pone.0099450. eCollection 2014.

27.

Sustained virological response to antiviral treatment in chronic hepatitis C patients may be predictable by HCV-RNA clearance in peripheral blood mononuclear cells.

Coppola N, De Pascalis S, Pisaturo M, Paradiso L, Macera M, Capoluongo N, Alessio L, Stanzione M, Sagnelli C, Minichini C, Sagnelli E.

J Clin Virol. 2013 Dec;58(4):748-50. doi: 10.1016/j.jcv.2013.09.014. Epub 2013 Sep 23. No abstract available.

PMID:
24140030
28.

Preparation, characterization and antibacterial activity of poly(epsilon-caprolactone) electrospun fibers loaded with amoxicillin for controlled release in biomedical applications.

Valarezo E, Stanzione M, Tammaro L, Cartuche L, Malagón O, Vittoria V.

J Nanosci Nanotechnol. 2013 Mar;13(3):1717-26.

PMID:
23755579
29.

Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.

Bruno S, Saibeni S, Bagnardi V, Vandelli C, De Luca M, Felder M, Fracanzani AL, Prisco C, Vitaliani G, Simone L, Gaeta GB, Stanzione M, Persico M, Furlan C, Stroffolini T, Salerno F, Maisonneuve P, Almasio PL; AISF (Italian Association for the Study of the Liver) – EPA-SCO Collaborative Study Group.

Am J Gastroenterol. 2013 Jul;108(7):1112-22. doi: 10.1038/ajg.2013.110. Epub 2013 Jun 4.

PMID:
23732467
30.

Enhanced in vitro antitumor activity of a titanocene complex encapsulated into polycaprolactone (PCL) electrospun fibers.

Stanzione M, Petillo O, Calarco A, Valarezo E, Napoli M, Longo P, Riccitiello F, Vittoria V, Peluso G.

J Appl Biomater Funct Mater. 2013 Jun 24;11(1):e61-70. doi: 10.5301/JABFM.5000155.

PMID:
23728536
31.

Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.

Sagnelli E, Pisaturo M, Stanzione M, Messina V, Alessio L, Sagnelli C, Starace M, Pasquale G, Coppola N.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1174-1180.e11. doi: 10.1016/j.cgh.2013.03.025. Epub 2013 Apr 13.

PMID:
23591280
32.

Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection.

Coppola N, Stanzione M, Messina V, Pisaturo M, De Pascalis S, Macera M, Tonziello G, Fiore M, Sagnelli C, Pasquale G, Sagnelli E.

J Viral Hepat. 2012 Dec;19(12):890-6. doi: 10.1111/j.1365-2893.2012.01627.x. Epub 2012 Jun 20.

PMID:
23121368
33.

Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings.

Coppola N, Tonziello G, Pisaturo M, Messina V, Guastafierro S, Fiore M, Iodice V, Sagnelli C, Stanzione M, Capoluongo N, Pasquale G, Sagnelli E.

J Med Virol. 2011 Nov;83(11):1909-16. doi: 10.1002/jmv.22199. Epub 2011 Aug 23.

PMID:
21915865
34.

Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study.

Morisco F, Stroffolini T, Medda E, Amoruso DC, Almasio PL, Villa E, Zuin M, Paris B, Stanzione M, Caporaso N; NADIR Study Group.

J Viral Hepat. 2010 Jun;17(6):427-34. doi: 10.1111/j.1365-2893.2009.01200.x. Epub 2009 Sep 25.

PMID:
19780939
35.

[Spontaneous and treatment-induced virological dynamic in the plasma, PBMC and liver tissue in a patient with chronic HBV and HCV coinfection].

Stanzione M, Tonsiello G, Iodice V, Macera M, Sagnelli E, Piccinino F, Coppola N.

Infez Med. 2009 Jun;17(2):109-14. Italian.

36.

Early discontinuation of ribavirin in HCV-2 and HCV-3 patients responding to Peg-interferon alpha-2a and ribavirin.

Andriulli A, Cursaro C, Cozzolongo R, Iacobellis A, Valvano MR, Mangia A, Minerva N, Bacca D, Stanzione M, Scuteri A, Montalto G, Andreone P.

J Viral Hepat. 2009 Jan;16(1):28-35. doi: 10.1111/j.1365-2893.2008.01044.x. Epub 2008 Aug 28.

PMID:
18761603
37.

Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study.

Sagnelli E, Imparato M, Coppola N, Pisapia R, Sagnelli C, Messina V, Piai G, Stanzione M, Bruno M, Moggio G, Caprio N, Pasquale G, Del Vecchio Blanco C.

J Med Virol. 2008 Sep;80(9):1547-53. doi: 10.1002/jmv.21239.

PMID:
18649338
38.

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.

Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S; Italian Association of the Study of the Liver Disease (AISF).

Am J Gastroenterol. 2008 Aug;103(8):1966-72. doi: 10.1111/j.1572-0241.2008.01912.x. Epub 2008 Jul 12.

PMID:
18637087
39.

Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection.

Coppola N, Pisapia R, Tonziello G, Martini S, Imparato M, Piai G, Stanzione M, Sagnelli C, Filippini P, Piccinino F, Sagnelli E.

Antivir Ther. 2008;13(2):307-18.

PMID:
18505182
40.

Viral blips during long-term treatment with standard or double dose lamivudine in HBe antigen negative chronic hepatitis B.

Stornaiuolo G, Stanzione M, Brancaccio G, Cuomo G, Precone V, Di Biase S, Felaco FM, Piccinino F, Gaeta GB.

World J Gastroenterol. 2007 Nov 14;13(42):5642-7.

41.

[Therapeutic options in chronic HBV infection].

Felaco FM, Leone S, Stanzione M.

Infez Med. 2007 Sep;15(3):149-59. Review. Italian.

42.

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta.

Niro GA, Ciancio A, Gaeta GB, Smedile A, Marrone A, Olivero A, Stanzione M, David E, Brancaccio G, Fontana R, Perri F, Andriulli A, Rizzetto M.

Hepatology. 2006 Sep;44(3):713-20.

PMID:
16941685
43.

Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP).

Pignata S, Gallo C, Daniele B, Elba S, Giorgio A, Capuano G, Adinolfi LE, De Sio I, Izzo F, Farinati F, Del Naja C, Stanzione M, Castiglione F, Marone G, Cuomo O, Felder M, Gaeta GB, De Maio E, Di Maio M, Signoriello G, Perrone F; CLIP Investigators.

Crit Rev Oncol Hematol. 2006 Sep;59(3):243-9. Epub 2006 Aug 17.

PMID:
16916608
44.

Removal of low molecular weight phenols from olive oil mill wastewater using microalgae.

Pinto G, Pollio A, Previtera L, Stanzione M, Temussi F.

Biotechnol Lett. 2003 Oct;25(19):1657-9.

PMID:
14584924
45.

Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C.

Gaeta GB, Precone DF, Felaco FM, Bruno R, Spadaro A, Stornaiuolo G, Stanzione M, Ascione T, De Sena R, Campanone A, Filice G, Piccinino F.

Aliment Pharmacol Ther. 2002 Sep;16(9):1633-9.

46.

Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial.

Perrone F, Gallo C, Daniele B, Gaeta GB, Izzo F, Capuano G, Adinolfi LE, Mazzanti R, Farinati F, Elba S, Piai G, Calandra M, Stanzione M, Mattera D, Aiello A, De Sio I, Castiglione F, Russo M, Persico M, Felder M, Manghisi OG, De Maio E, Di Maio M, Pignata S; Cancer of Liver Italian Program (CLIP) Investigators.

Curr Pharm Des. 2002;8(11):1013-9.

PMID:
11945148
47.

Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment.

Sagnelli E, Coppola N, Scolastico C, Mogavero AR, Stanzione M, Filippini P, Felaco FM, Piccinino F.

J Med Virol. 2001 Dec;65(4):681-7.

PMID:
11745931
48.

Interferon-alpha plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study.

Gaeta GB, Stornaiuolo G, Stanzione M, Ascione T, Pasquazzi C, Taliani G, Cimino L, Budillon G, Piccinino F.

J Viral Hepat. 2001 Jul;8(4):284-6.

PMID:
11454180
49.

Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53.

Vikhanskaya F, Clerico L, Valenti M, Stanzione MS, Broggini M, Parodi S, Russo P.

Int J Cancer. 1997 Jul 3;72(1):155-9.

50.

Slowly progressive aphasia associated with surface dyslexia.

Chiacchio L, Grossi D, Stanzione M, Trojano L.

Cortex. 1993 Mar;29(1):145-52.

PMID:
7682490

Supplemental Content

Loading ...
Support Center